Last updated on August 2019
ADYNOVATE Drug Use-Results Survey
Brief description of study
The purpose of this survey is to understand the following items in the actual clinical use of ADYNOVATE in patients:
- Unexpected adverse drug reactions
- Occurrence of adverse drug reactions in the actual clinical use
- Factors that may affect safety and efficacy
- Occurrence of Factor VIII inhibitor development in patients with coagulation factor VIII deficiency (hereinafter hemophilia A)
- Safety and efficacy for hemophilia A patients who received routine prophylactic therapy and on-demand therapy
Clinical Study Identifier: NCT03169972